Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Other financing activities (2020)

Treace Medical Concepts' Other financing activities history spans 1 years, with the latest figure at $8000.0 for Q1 2020.

  • For Q1 2020, Other financing activities changed N/A year-over-year to $8000.0; the TTM value through Dec 2021 reached $8000.0, changed N/A, while the annual FY2025 figure was $1.2 million, N/A changed from the prior year.
  • Other financing activities reached $8000.0 in Q1 2020 per TMCI's latest filing.
  • In the past five years, Other financing activities ranged from a high of $8000.0 in Q1 2020 to a low of $8000.0 in Q1 2020.